लोड हो रहा है...
TARGETED THERAPY: Generic imatinib — impact on frontline and salvage therapy for CML
Imatinib has revolutionized the treatment of chronic myeloid leukaemia (CML). In 2016, generic imatinib will be introduced into the US market. We analyse the potential impact of this new product on patient care and optimal CML therapy, and comment on the effect that distorted cancer drug pricing in...
में बचाया:
| में प्रकाशित: | Nat Rev Clin Oncol |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5450934/ https://ncbi.nlm.nih.gov/pubmed/27098218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2016.59 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|